NCT01153841View on ClinicalTrials.gov

Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 17, 2011

Primary Completion Date

July 26, 2011

Study Completion Date

July 26, 2011

Conditions
Infections, StreptococcalStreptococcus Pneumoniae Vaccines
Interventions
BIOLOGICAL

Synflorix™( GSK1024850A)

Intramuscular, 3 doses

BIOLOGICAL

Infanrix hexa™

Intramuscular, 3 doses

Trial Locations (1)

Unknown

GSK Investigational Site, Ho Chi Minh City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01153841 - Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam | Biotech Hunter | Biotech Hunter